Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Inventory (2021 - 2025)

Historic Change in Inventory for Macrogenics (MGNX) over the last 5 years, with Q3 2025 value amounting to -$525000.0.

  • Macrogenics' Change in Inventory fell 12465.95% to -$525000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 30932.05%. This contributed to the annual value of $2.2 million for FY2024, which is 105130.43% up from last year.
  • Per Macrogenics' latest filing, its Change in Inventory stood at -$525000.0 for Q3 2025, which was down 12465.95% from -$151000.0 recorded in Q2 2025.
  • Macrogenics' 5-year Change in Inventory high stood at $9.4 million for Q1 2025, and its period low was -$894000.0 during Q3 2021.
  • For the 5-year period, Macrogenics' Change in Inventory averaged around $898789.5, with its median value being $34000.0 (2023).
  • As far as peak fluctuations go, Macrogenics' Change in Inventory tumbled by 56140.35% in 2023, and later soared by 3481111.11% in 2025.
  • Quarter analysis of 5 years shows Macrogenics' Change in Inventory stood at $842000.0 in 2021, then plummeted by 56.77% to $364000.0 in 2022, then tumbled by 57.42% to $155000.0 in 2023, then rose by 6.45% to $165000.0 in 2024, then tumbled by 418.18% to -$525000.0 in 2025.
  • Its last three reported values are -$525000.0 in Q3 2025, -$151000.0 for Q2 2025, and $9.4 million during Q1 2025.